BIOPIXLAR®

Fluicell has developed Biopixlar, a game-changing bioprinting platform capable of producing tissue models by printing at the level…

Read more
03 Jun 2019

WE SOLD A BIOPEN SYSTEM TO UNIVERSITY OF CAMBRIDGE

We have sold a BioPen® Prime System to University of Cambridge in UK. The BioPen® System enables researchers to…

Read more
19 Jun 2019

Welcome to new Fluicell place at Mölndal!

We are extremely happy to announce that we have just moved to bigger premises located in Mölndal. This…

Read more
06 May 2019

STERILE BIOPEN PIPETTE TIPS ARE AVAILABLE

We are pleased to announce that sterile BioPen PRIME and FLEX pipette tips are now available. From conception…

Read more
10 Apr 2019

We sold a BioPen System to Rockefeller University

We have sold a BioPen® Prime System to Rockefeller University, NYC, USA. The BioPen® System enables researchers to…

Read more
02 Apr 2019

First beta testing agreement for Biopixlar with Cellectricon

Fluicell AB today announces that the company has entered into an agreement with Cellectricon AB for beta testing…

Read more
28 Mar 2019

We are at BPS 2019 in Baltimore

So excited to be at the 63rd Annual Meeting of the Biophysical Society in Baltimore between the 2-6…

Read more
04 Mar 2019

Fluicell Retrospective 2018

2018 has been a dynamic and successful year!

Read more
18 Feb 2019

Investigating cell stress for better health

We would like to congratulate our CTO, Gavin Jeffries for his paper “Label-free spatio-temporal monitoring of cytosolic mass,…

Read more
12 Feb 2019